Company: PFSA
Filing Date: 2025-07-18
Form Type: 8-K
Source: 0001213900-25-065686
Chunk: 14

Company: Profusa, Inc.
Filing Date: 2025-07-18
Form: 8-K
Item: Item 2.03
Chunk 14
---
, together with the cash we expect
to generate from future operations will provide sufficient funding to support initial commercial operations. Until we generate sufficient
operating cash flow to cover our operating expenses, working capital needs and planned capital expenditures, or if circumstances evolve
differently than anticipated, we expect to utilize a combination of equity and debt financing to fund any future capital needs. If we
raise funds by issuing equity securities, dilution to stockholders may result. Any equity securities issued may also provide for rights,
preferences, or privileges senior to those of holders of common stock. If we raise funds by issuing debt securities, these debt securities
would have rights, preferences, and privileges senior to those of preferred and common stockholders. The terms of debt securities or borrowings
could impose significant restrictions on our operations. The capital markets are currently experiencing, and may continue to experience
in the future, periods of upheaval that could impact the availability and cost of equity and debt financing.

Our principal uses of cash
in recent periods have been funding our research and development activities and other personnel costs. Near-term capital requirements
through March 31, 2025 leading to and supporting initial commercialization are estimated to total approximately $6.0 million and include
further research and development to enable us to obtain the required regulatory approvals, manufacturing, commercialization and wide-scale
marketing for our Lumee Oxygen and Lumee Glucose devices. Our future capital requirements will depend on many factors, including our revenue
growth rate, the timing and the amount of cash received from our customers, the expansion of sales and marketing activities, the timing
and extent of spending to support development efforts. In the future, we may enter into arrangements to acquire or invest in complementary
businesses, products, and technologies. We may be required to seek additional equity or debt financing. In the event that we require additional
financing we may not be able to raise such financing on acceptable terms or at all. If we are unable to raise additional capital or generate
cash flows necessary to continue our research and development and invest in continued innovation, we may not be able to compete successfully,
which would harm our business, results of operations, and financial condition. If adequate funds are not available, we may need to reconsider
our production investments, the pace of our production ramp-up, expansion plans or limit our research and development activities, which
could have a material adverse impact on our business prospects and results of operations.

Cash Flow Summary

The following table summarizes our cash flows